Who won: NHS Generic Pharmaceuticals - Lenalidomide, Pomalidomide & Thalidomide

About this contract

NHS National Framework for Lenalidomide, Pomalidomide & Thalidomide. Offer reference number: CM/PHG/24/5716 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months. Periods of call-offs under the framework agreement: CM/PHG/24/5716/01– NHS National Framework for Lenalidomide, Pomalidomide & Thalidomide. CESW: (Midlands and Southwest): 1st June 2026 – 31st May 2028 NWLN: (Northwest and London North): 1st June 2026 – 31st May 2028 LSNE: (London South and Northeast): 1st June 2026 – 31st May 2028

Who won contracts like this

• ✓Answer against the marking scheme, not the question text — NHS England scores each response, so map your evidence to the published criteria and weightings.
• ✓Lead with evidenced capability and social value — for public sector work these usually outweigh price.
• ✓Show recent, comparable delivery: name similar public sector contracts you've delivered for public bodies, with measurable outcomes.
• ✓This one's been awarded — but NHS England retenders on a cycle. Get matched the day the next one lands and start your draft early.

BidWriter drafts your responses from your company profile, scores them against the marking scheme, and tracks your whole pipeline. Free to start — no card needed.

Related resources

Similar contracts